Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEGeneralM&A20 Oct 2026

Dr Agarwals Eye Hospital Ltd-$

Outcome of Board Meeting held on October 20, 2026, in connection with a Material Update on Scheme of Amalgamation between Dr. Agarwal''s Eye Hospital Limited and Dr. Agarwal''s Health Care Limited, is enclosed.

Dr. Agarwal's Eye Hospital Ltd has announced the outcome of its board meeting, where it has approved the effectiveness of the scheme of amalgamation between Dr. Agarwal's Eye Hospital Ltd and Dr. Agarwal's Health Care Ltd. The scheme will become effective from November 1, 2026, and the record date for allotment of consideration shares has been fixed as November 18, 2026.

Read more →📎 1 attachment
NSEGeneral UpdatesMgmt Change20 Oct 2026

Moneyview Limited

General Updates

Moneyview Limited has announced that its Board of Directors has approved certain resolutions, including the ratification of the Moneyview Employees Stock Option Plan 2015, extension of ESOP benefits to subsidiary companies, provision of funds for share purchase, alteration of Articles of Association, and reclassification of authorized share capital.

Read more →📎 1 attachment
BSEGeneralM&A20 Oct 2026

Dr. Agarwals Health Care Ltd

Outcome of Board Meeting held on October 20, 2026 in connection with a Material Update on Scheme of Amalgamation between Dr. Agarwal''s Eye Hospital Limited and Dr. Agarwal''s Health Care Limited, is enclosed.

Dr. Agarwal's Health Care Ltd has announced the outcome of its Board Meeting held on October 20, 2026, in connection with a Material Update on the Scheme of Amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited. The Board has noted, considered, and approved the effectiveness of the Scheme, alteration of the authorized share capital, and fixation of the record date for allotment of consideration shares to eligible shareholders.

Read more →📎 1 attachment
NSEGeneral Updates▼ NegativeRegulatory20 Oct 2026

Schaeffler India Limited

General Updates

Schaeffler India Limited has informed the Exchange about General Updates regarding the CEO & Managing Director, Mr. Harsha Gopal Kadam, being taken into custody for investigation by the Talegaon MIDC Police Station, Pimpri Chinchwad Police Commissionerate, under the provisions of the Bharatiya Nyaya Sanhita, 2023, in relation to an investigation being conducted by the Authority with respect to an accident in the factory premises of the Company on June 9, 2026.

Read more →📎 1 attachment
BSEGeneralFundraise20 Oct 2026

Retaggio Industries Ltd

The company in the board meeting held today has allotted the Equity shares to the non-promoter pursuant to conversion of warrants into Equity Shares.

Retaggio Industries Ltd has allotted 504,000 equity shares to non-promoter Sanjay Jaideo Poddar pursuant to conversion of warrants into equity shares. The allotment was made at Rs. 26/- per share, with 25% of the consideration paid at the time of subscription and the balance 75% payable on exercise of the warrants. The paid-up equity share capital of the company has increased to Rs. 20,99,21,600/- divided into 2,09,92,160 equity shares of face value Rs. 10/- each.

Read more →📎 1 attachment
BSEGeneralPromoter Reclassif.20 Oct 2026

Advanced Enzyme Technologies Ltd

Intimation of receipt of request from Promoter Group Member for reclassification from Promoter Group Category to Public Category Shareholders under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Advanced Enzyme Technologies Ltd has received a request from a promoter group member, Snehal Shamsunder Soni, to reclassify his shareholding from the 'Promoter Group' category to the 'Public' category under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment
BSEGeneralFundraise20 Oct 2026

Dhruva Capital Services Ltd

Outcome of Board Meeting

Dhruva Capital Services Ltd has announced the outcome of its board meeting, where the board has approved the raising of funds through the issuance of equity shares via Qualified Institutional Placement (QIP) for up to Rs.160 Crores.

Read more →📎 1 attachment
BSEGeneral▲ PositiveOrder Win20 Oct 2026

PVP Ventures Ltd

Signing and Issuance of Letter of Intent to Elekta Solutions AB, Sweden, for the proposed procurement, of ten (10) Harmony, linear accelerator (LINAC) systems, Deal value is expected to be between 11 to 15 million dollars USD.

PVP Ventures Ltd (now Evervie Health Ltd) has signed a Letter of Intent with Elekta Solutions AB, Sweden, for the proposed procurement of ten HARMONY linear accelerator (LINAC) systems. The deal value is expected to be between 11 to 15 million dollars USD. The company has also launched its new official website.

Read more →📎 1 attachment
NSEGeneral UpdatesFundraise20 Oct 2026

Orchid Pharma Limited

General Updates

Orchid Pharma Limited has informed the Exchange about General Updates, specifically that the Board of Directors has approved a proposal to explore the potential market opportunities for raising funds by issuing equity shares or other eligible securities, up to Rs. 600 Crores.

Read more →📎 1 attachment
NSEGeneral UpdatesFundraise20 Oct 2026

Indian Overseas Bank

General Updates

Indian Overseas Bank has received SEBI approval for issuance of up to 10 crore fresh equity shares to eligible employees under Employee Stock Purchase Scheme (ESPS) to comply with minimum public shareholding (MPS) requirements.

Read more →📎 1 attachment
NSEGeneral UpdatesESG20 Oct 2026

NLC India Limited

General Updates

NLC India Limited has informed the Exchange about General Updates, specifically that CRISIL ESG Ratings & Analytics Ltd has assigned an Environmental, Social and Governance (ESG) rating of 'CRISIL ESG 57' for the Company.

Read more →📎 1 attachment
NSEGeneral UpdatesRegulatory20 Oct 2026

Yes Bank Limited

General Updates

Yes Bank Limited has informed the Exchange about an update on the outcome of the Board Meeting dated October 17, 2026, regarding the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The update corrects an earlier disclosure stating that the Joint Statutory Auditors had issued a modified opinion on the standalone and consolidated financial results for Q2 and H1 2026, to instead express a qualified conclusion in their Limited Review Report.

Read more →📎 1 attachment
← PreviousPage 90 of 526Next →